New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Novel research shows older breast cancer survivors experience accelerated aging, worse functional outcomes

Novel research shows older breast cancer survivors experience accelerated aging, worse functional outcomes

by Colleen McDonald,Medical College of WisconsinLongitudinal changes in epigenetic aging between the first and second blood samples among Black or non-Hispanic White older breast cancer survivor
Oncology January 21,2024
Novel research shows older breast cancer survivors experience accelerated aging, worse functional outcomes

Novel research shows older breast cancer survivors experience accelerated aging, worse functional outcomes

by Colleen McDonald,Medical College of WisconsinLongitudinal changes in epigenetic aging between the first and second blood samples among Black or non-Hispanic White older breast cancer survivor
Oncology January 21,2024
'Super recognizers' can learn faces from fragments

'Super recognizers' can learn faces from fragments

byUniversity of New South WalesSuper-recognizers are more accurate than typical viewers even with only 12% of face information available on each fixation. Diamond shows group mean and 95% confid
Neurology January 21,2024
'Super recognizers' can learn faces from fragments

'Super recognizers' can learn faces from fragments

byUniversity of New South WalesSuper-recognizers are more accurate than typical viewers even with only 12% of face information available on each fixation. Diamond shows group mean and 95% confid
Neurology January 21,2024
Atogepant prevents migraine in adults

Atogepant prevents migraine in adults

Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 inJAMA Network Open.Richard B. Lipton, M.D., from Albe
Neurology January 21,2024
Atogepant prevents migraine in adults

Atogepant prevents migraine in adults

Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 inJAMA Network Open.Richard B. Lipton, M.D., from Albe
Neurology January 21,2024
Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainMost high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without
Oncology January 21,2024
Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

Prostate cancer 'test by request' policies drive overdiagnosis and inequity with minimal benefit, argue experts

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainMost high income countries, including the U.K., do not have a national prostate cancer screening program, but instead allow men without
Oncology January 21,2024
Breaks in 'junk' DNA give scientists new insight into neurological disorders

Breaks in 'junk' DNA give scientists new insight into neurological disorders

byUniversity of SheffieldCredit: Pixabay/CC0 Public DomainJunk DNA could unlock new treatments for neurological disorders as scientists discover its breaks and repairs affect our protection agai
Neurology January 21,2024
Breaks in 'junk' DNA give scientists new insight into neurological disorders

Breaks in 'junk' DNA give scientists new insight into neurological disorders

byUniversity of SheffieldCredit: Pixabay/CC0 Public DomainJunk DNA could unlock new treatments for neurological disorders as scientists discover its breaks and repairs affect our protection agai
Neurology January 21,2024
A step towards precision oncology for patients with metastatic urothelial carcinoma

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University
Oncology January 21,2024
A step towards precision oncology for patients with metastatic urothelial carcinoma

A step towards precision oncology for patients with metastatic urothelial carcinoma

byUniversity of BonnCredit: Pixabay/CC0 Public DomainDr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University
Oncology January 21,2024
AAN issues evidence-in-focus article on aducanumab

AAN issues evidence-in-focus article on aducanumab

byAmerican Academy of NeurologyCredit: Pixabay/Pete Linforth.To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's d
Neurology January 21,2024
AAN issues evidence-in-focus article on aducanumab

AAN issues evidence-in-focus article on aducanumab

byAmerican Academy of NeurologyCredit: Pixabay/Pete Linforth.To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's d
Neurology January 21,2024
Type 2 diabetes accelerates brain aging and cognitive decline

Type 2 diabetes accelerates brain aging and cognitive decline

byeLifeThis image shows the effects of aging effects on the brain, further exacerbated in type 2 diabetes. Credit: Lilianne Mujica-Parodi (CC BY 4.0)Scientists have demonstrated that normal brai
Neurology January 21,2024
Type 2 diabetes accelerates brain aging and cognitive decline

Type 2 diabetes accelerates brain aging and cognitive decline

byeLifeThis image shows the effects of aging effects on the brain, further exacerbated in type 2 diabetes. Credit: Lilianne Mujica-Parodi (CC BY 4.0)Scientists have demonstrated that normal brai
Neurology January 21,2024
13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

by Elana GotkineThirteen percent of patients with definite anti-N-methyl-D-aspartate receptor encephalitis (ANMDARE) have suicidal thoughts and behaviors during the acute phase of the disease, accordi
Neurology January 21,2024
13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

13 percent of patients with anti-NMDA receptor encephalitis have suicidal thoughts

by Elana GotkineThirteen percent of patients with definite anti-N-methyl-D-aspartate receptor encephalitis (ANMDARE) have suicidal thoughts and behaviors during the acute phase of the disease, accordi
Neurology January 21,2024
'Jumping' genes yield new clues to origins of neurodegenerative disease

'Jumping' genes yield new clues to origins of neurodegenerative disease

by Bill Hathaway,Yale UniversityGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.011Massive, repetitive stretches of DNA in the human genome may harbor hints ab
Neurology January 21,2024
'Jumping' genes yield new clues to origins of neurodegenerative disease

'Jumping' genes yield new clues to origins of neurodegenerative disease

by Bill Hathaway,Yale UniversityGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.011Massive, repetitive stretches of DNA in the human genome may harbor hints ab
Neurology January 21,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com